Discovery of Selective Menaquinone Biosynthesis Inhibitors against Mycobacterium tuberculosis
- 26 March 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 55 (8), 3739-3755
- https://doi.org/10.1021/jm201608g
Abstract
Aurachin RE (1) is a strong antibiotic that was recently found to possess 1,4-dihydroxy-2-naphthoate prenyltransferase (MenA) and bacterial electron transport inhibitory activities. Aurachin RE is the only molecule in a series of aurachin natural products that has the chiral center in the alkyl side chain at C9′-position. To identify selective MenA inhibitors against Mycobacterium tuberculosis, a series of chiral molecules were designed based on the structures of previously identified MenA inhibitors and 1. The synthesized molecules were evaluated in in vitro assays, including MenA enzyme and bacterial growth inhibitory assays. We could identify novel MenA inhibitors that showed significant increase in potency of killing nonreplicating M. tuberculosis in the low oxygen recovery assay (LORA) without inhibiting other Gram-positive bacterial growth even at high concentrations. The MenA inhibitors reported here are useful new pharmacophores for the development of selective antimycobacterial agents with strong activity against nonreplicating M. tuberculosis.Keywords
This publication has 45 references indexed in Scilit:
- Vitamin K2 in Electron Transport System: Are Enzymes Involved in Vitamin K2 Biosynthesis Promising Drug Targets?Molecules, 2010
- Unique Roles of DosT and DosS in DosR Regulon Induction and Mycobacterium tuberculosis DormancyInfection and Immunity, 2009
- Mechanism-based inhibitors of MenE, an acyl-CoA synthetase involved in bacterial menaquinone biosynthesisBioorganic & Medicinal Chemistry Letters, 2008
- A Quinoline Antibiotic from Rhodococcus erythropolis JCM 6824The Journal of Antibiotics, 2008
- Discovery of 1,4-Didydroxy-2-naphthoate Prenyltransferase Inhibitors: New Drug Leads for Multidrug-Resistant Gram-Positive PathogensJournal of Medicinal Chemistry, 2007
- Metronidazole plus Rifampin Sterilizes Long-Term Dormant Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2007
- Low-Oxygen-Recovery Assay for High-Throughput Screening of Compounds against Nonreplicating Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2007
- New TB Drug Promises Shorter, Simpler TreatmentScience, 2004
- The roles of hydrogenases 3 and 4, and the F0F1‐ATPase, in H2 production by Escherichia coli at alkaline and acidic pHFEBS Letters, 2002
- Basic local alignment search toolJournal of Molecular Biology, 1990